Global Diabetes Monitoring Device Market, By Product Type (Self-Monitoring Glucose Devices, Continuous Glucose Monitoring Devices), By Indication (Type-I Diabetes, Type-II Diabetes, Gestational Diabetes), By Method (Invasive, Non-Invasive), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Centers, and Others) and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa)- Trends, Analysis and Forecast till 2029

Diabetes monitoring device is used to regularly monitor to keep the blood sugar level within normal ranges. Symptoms of patients suffering from diabetes include frequent urination, excessive hunger, and increased thirst.

North America dominates the global diabetes monitoring device market and is expected to maintain its dominancy over the forecast period owing to government initiatives undertaken for the prevention of diabetes. Also, presence of leading players coupled with advanced technical implementation in drug discovery procedures are the factors supporting growth of the target market in the region.

The market in Asia Pacific is expected to show significant growth rate in global diabetes monitoring device market over the forecast period. This can be attributed to rising demand for diabetes monitoring devices owing to increase in development of cost-effective diabetes monitoring devices in the region. 

However, adverse effects associated with some of the diabetes care devices is a major factor expected to hamper growth of the global diabetes monitoring device market over the forecast period. Also, high cost of these devices coupled with the calibration errors associated with these devices are factors expected to hinder growth of the global diabetes monitoring device market over the forecast period.

The global diabetes monitoring device market has been segmented on the basis of product type, indication, approach, end user, and region. The product type segment includes self-monitoring glucose devices and continuous glucose monitoring devices. On the basis of indication the global diabetes monitoring device market has been segmented as type-i diabetes, type-ii diabetes, and gestational diabetes. The method segment includes invasive and non-invasive. On the basis of end user the global diabetes monitoring device market has been segmented as hospitals, clinics, ambulatory surgical centers, home care centers, and others.

On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the global diabetes monitoring device market includes Bayer Healthcare AG, Medtronic, Dexcom, Sanofi, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga Medical, and Bigfoot Biomedical.